Related Experiment Video
Updated: Apr 24, 2026

11:31
Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting
Published on: November 30, 2015
15.8K
Causal Associations Between Immune Cell-Specific Gene Expression and Major Depressive Disorder: A Single-Cell
Xin Mo1, Dongren Sun2, Fangfang Li3
1Department of Neurosurgery, The Second People's Hospital of Hunan Provincial (Hunan Provincial Brain Hospital), Changsha, China.
Summary
Major depressive disorder (MDD) involves immune dysregulation. This study links immune cell gene expression to MDD using genetic data, identifying PTCH1 and MTHFD1L as potential therapeutic targets for precision immunotherapy.
Area of Science:
- Immunology
- Psychiatry
- Genetics
Background:
- Major depressive disorder (MDD) is a common psychiatric condition linked to immune system dysfunction.
- Understanding the genetic basis of immune cell involvement in MDD is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the causal relationship between gene expression in specific immune cell types and MDD.
- To identify novel molecular targets for precision immunotherapy in MDD.
Main Methods:
- Integrated single-cell cis-eQTL data with MDD GWAS summary statistics.
- Employed single-cell transcriptome-wide Mendelian randomization (scTWMR) and Bayesian colocalization.
- Conducted functional analyses including enrichment, protein-protein interaction, and druggability assessment.
Main Results:
- Identified six significant gene-cell associations in CD4+ T cells, immature B cells, and plasma cells.
- Found strong colocalization evidence for PTCH1, MTHFD1L, and RP11-293M10.2.
- Enrichment analyses implicated Hedgehog signaling and folate metabolism pathways.
Conclusions:
- Established a genetically predicted causal link between immune cell-specific gene expression and MDD.
- PTCH1 and MTHFD1L are validated as potential drug targets for MDD.
- The study provides a framework for discovering and validating gene targets for precision immunotherapy.

